BioRestorative Therapies (BRTX) Earnings Date & Reports
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BRTX is expected to report earnings to fall 30.00% to -7 cents per share on November 18
Q3'26
Est.
$-0.07
Q1'26
Beat
by $0.19
Q4'25
Beat
by $0.01
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.08
The last earnings report on May 20 showed earnings per share of -10 cents, beating the estimate of -29 cents. With 2.12K shares outstanding, the current market capitalization sits at 3.63M.